DNA demethylation agents and HDAC inhibitors, though, could be used as intravesical drugs for restoring prostasin expression in TCC and suppressing tumor invasion and metastasis once an anti-invasion role for prostasin in TCC is established. This evidence concerns the gene HDAC9 and tarsal-carpal coalition syndrome.